The Cannabis Use Disorder market is experiencing significant evolution driven by increasing prevalence of cannabis-related dependency cases globally. Industry participants are leveraging innovative treatment approaches amid expanding regulatory frameworks and rising awareness, resulting in dynamic shifts in industry size and market insights.



Market Size and Overview

The cannabis use disorder market is estimated to be valued at USD 1.80 Bn in 2025 and is expected to reach USD 3.40 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.5% from 2025 to 2032.

This growth is propelled by expanding patient populations seeking clinical intervention and increased development of novel therapeutics targeting cannabis dependency.

Cannabis Use Disorder Market research highlights rising investments in clinical studies and growing market revenue from emerging regions, underpinning the robust market forecast. The cannabis use disorder market report indicates steady progress in drug development pipelines and amplified market scope through diversified treatment modalities.



Key Takeaways

- Dominating Region: North America continues to dominate the cannabis use disorder market trends, backed by the US FDA's expanded approvals in 2024 and comprehensive healthcare infrastructure supporting treatment adoption.

- Fastest Growing Region: The Asia Pacific region is witnessing rapid market growth due to increasing incidence rates and growing healthcare expenditure, especially in countries like Japan and South Korea.

- Market Segments:

- Therapeutics:

- Dominant sub-segment: Oral medications, with recent launch of targeted cannabinoid receptor antagonists in 2025.

- Fastest-growing sub-segment: Injectable therapies, supported by advanced clinical trials conducted in 2024 in Europe.

- End User:

- Dominant sub-segment: Hospitals, driving the largest industry share through integrated treatment programs.

- Fastest-growing sub-segment: Outpatient clinics, boosted by policy reforms encouraging community-based management.

- Treatment Approach:

- Dominant sub-segment: Pharmacological interventions, led by market players innovating novel compounds.

- Fastest-growing sub-segment: Behavioral therapies, increasingly incorporated alongside medication for holistic care.



Market Key Trends

A predominant trend shaping the cannabis use disorder market trends is the surge in development and approval of novel cannabinoid receptor modulators. In 2024, a breakthrough product received regulatory clearance in Europe, marking significant progress in targeted pharmacological treatment. This product leverages a unique mechanism of action to reduce cannabis cravings and withdrawal symptoms, positioning it as a promising alternative to conventional therapies.

Market dynamics indicate growing collaborations between pharmaceutical companies and research institutions to optimize formulation efficacy and patient adherence. Furthermore, strategic expansion of clinical trial sites globally has diversified patient recruitment, strengthening market growth strategies. This development is expected to enhance market revenue and provide viable market opportunities over the forecast period.



Key Players

Key players operating in the Cannabis Use Disorder market include Aelis Farma, Indivior, Pfizer, Corbus Pharmaceuticals, and Zynerba Pharmaceuticals, among others.

These market companies are actively pursuing innovation-centric growth strategies; for example, Aelis Farma advanced a phase III trial for a novel non-opioid oral treatment in 2025. Indivior expanded its geographic footprint by entering key Asian markets in late 2024 to tap into rising regional demand. Pfizer boosted market presence through strategic partnerships focused on behavioral intervention add-ons, contributing to enhanced treatment outcomes.

Additionally, Corbus Pharmaceuticals adopted a licensing agreement approach in 2025 to accelerate drug commercialization, directly impacting market share capture. These concerted efforts by market players underscore a highly competitive and innovation-driven market landscape.



FAQs



1. Who are the dominant players in the Cannabis Use Disorder market?

Key players include Aelis Farma, Indivior, Pfizer, Corbus Pharmaceuticals, and Zynerba Pharmaceuticals, which are leading innovations and expanding their market presence through clinical trials, strategic partnerships, and geographic expansions.



2. What will be the size of the Cannabis Use Disorder market in the coming years?

The market size is projected to grow from USD 1.80 billion in 2025 to USD 3.40 billion by 2032, demonstrating a CAGR of 9.5% fueled by increased treatment adoption and novel drug approvals.



3. Which end-user segments hold the largest growth opportunity in this market?

Hospitals dominate the end-user segment currently, but outpatient clinics represent the fastest growing segment due to improving access and evolving policy frameworks that support decentralized treatment options.



4. How will market development trends evolve over the next five years?

Market trends will be increasingly influenced by advancements in cannabinoid receptor-targeted therapies, with a focus on combination treatments incorporating behavioral therapies, driving enhanced patient compliance and improved outcomes.



5. What is the nature of the competitive landscape and challenges in the Cannabis Use Disorder market?

The competitive landscape is characterized by innovation-driven competition, with challenges including stringent regulatory approvals, high R&D costs, and market restraints such as stigma associated with cannabis dependency treatment.



6. What go-to-market strategies are commonly adopted in the Cannabis Use Disorder market?

Key market growth strategies include partnerships for clinical research, geographic expansion targeting emerging markets, product portfolio diversification, and collaboration with healthcare providers for integrated care delivery.

‣ Get this Report in Japanese Language: 大麻使用障害市場

‣ Get this Report in Korean Language:   대마사용장애시장

Author Bio:

Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163 )